IVF INVO Fertility, Inc. - Common Stock

NASDAQ · Health Care · Visualizza su SEC EDGAR ↗
$1,35
Prezzo · Ago 18, 2026
Fondamentali al Ago 14, 2026

IVF Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$1.35
Capitalizzazione di Mercato
P/E (TTM)
-0.0
EPS (TTM)
$-214.64
Ricavi (TTM)
$7M
Rendimento div.
ROE
D/E Debito/Patrimonio
Intervallo 52 sett.
$0 – $5

IVF Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $7M
4-point trend, +732.1%
2022-12-31 2025-12-31
EPS $-214.64
4-point trend, -1094.4%
2022-12-31 2025-12-31
Flusso di cassa libero
2023-12-31 2023-12-31
Margini

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
IVF
Mediana dei peer
P/E (TTM)
4-point trend, +100.0%
-0.0
27.5

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
IVF
Mediana dei peer

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
IVF
Mediana dei peer

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
IVF
Mediana dei peer
Revenue YoY (Ricavi YoY)
4-point trend, +732.1%
4.7%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
4-point trend, +732.1%
102.6%
Revenue CAGR 5Y (CAGR Ricavi 5Y)
4-point trend, +732.1%
45.8%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
IVF
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
4-point trend, -1094.4%
$-214.64

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
IVF
Mediana dei peer

IVF Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 5 analisti
  • Acquisto forte 1 20,0%
  • Compra 3 60,0%
  • Mantieni 1 20,0%
  • Vendi 0 0,0%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

1 analisti · 2026-08-19
Target mediano $20.00 +1381,5%
Target medio $20.00 +1381,5%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
-719.3%
Periodo EPS Actual EPS Stimato Sorpresa
31 Marzo 2026 $-3.38 $-1.26 -2.1%
31 Dicembre 2025 $-196.81 $-2.78 -194.0%
30 Settembre 2025 $-0.77 $-0.04 -0.73%
31 Dicembre 2024 $-3104.40 $-424.20 -2680.2%
30 Settembre 2023 $-0.70
30 Giugno 2023 $-3.06

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
IVF -0.0 4.7%
GCTK $4M 0.1 -399.4%
TNON
AEMD $3M -0.2 -134.5%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 18
Dati annuali Conto Economico per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +41142.2% $7M $7M $3M $822.2K $4M $1M $1M $494.4K $282.1K $50.9K $11.7K $16.6K
Cost of Revenue 11-point trend, +291.4% $30.6K $12.2K $2M $286.9K $126.3K $79.0K $133.7K $90.4K $52.0K $15.1K $7.8K ·
Gross Profit 9-point trend, +5409.5% · · · $490.7K $4M $948.5K $1M $404.0K $230.2K $35.8K $3.9K $8.9K
R&D Expense 6-point trend, +4880.00 · $4.9K $165.9K $544.0K $216.4K $398.4K $0 · · · · ·
SG&A Expense 12-point trend, +355.2% $8M $8M $7M $10M $9M $6M $3M $3M $870.6K $2M $599.0K $2M
Operating Expenses 12-point trend, +733.3% $14M $13M $10M $11M $9M $6M $3M $3M $870.6K $2M $599.0K $2M
Operating Income 12-point trend, -330.6% $-7M $-7M $-7M $-11M $-5M $-6M $-2M $-3M $-640.4K $-2M $-595.1K $-2M
Interest Expense 11-point trend, +1935.5% · $1M $925.9K $59.4K $1M $3M $387.6K $442.0K $20.9K $13.8K $32.0K $51.9K
Interest Income 2-point trend, -51.4% · · · · · $4.2K $8.6K · · · · ·
Other Non-op 9-point trend, +2936.0% $2M $-972.0K $-1M $-263.2K $-1M $-3M $-379.0K $-442.0K $-61.7K · · ·
Pretax Income 12-point trend, -216.7% $-5M $-8M $-8M $-11M $-7M $-8M $-2M $-3M $-702.2K $-2M $-5M $-2M
Income Tax 12-point trend, -150371.00 $-150.4K $140.2K $27.8K $2.9K $4.8K $36 $433 $0 $0 $0 $0 $0
Net Income 12-point trend, -1246.2% $-23M $-9M $-8M $-11M $-7M $-8M $-2M $-3M $-702.2K $-2M $-5M $-2M
EPS (Basic) 12-point trend, -1073100.0% $-214.64 $-3782.65 $-67.37 $-17.97 $-0.63 $-1.52 $-0.45 $-0.02 $0.00 $-0.02 $-0.04 $-0.02
EPS (Diluted) 12-point trend, -1073100.0% $-214.64 $-3782.65 $-67.37 $-17.97 $-0.63 $-1.52 $-0.45 $-0.02 $0.00 $-0.02 $-0.04 $-0.02
Shares (Basic) 12-point trend, -99.9% 117,083 2,514 119,264 606,130 10,632,413 5,489,738 4,854,878 147,333,051 141,305,050 139,186,557 128,567,615 112,672,160
Shares (Diluted) 12-point trend, -99.9% 117,083 2,514 119,264 606,130 10,632,413 5,489,738 4,854,878 147,333,051 141,305,050 139,186,557 128,567,615 112,672,160
EBITDA 5-point trend, -1014.0% · · $-7M · · · $-2M · $-637.6K $-2M $-589.4K ·
Stato Patrimoniale 25
Dati annuali Stato Patrimoniale per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +11055.6% $2M $619.5K $232.4K $90.1K $6M $10M $1M $212.2K $25.8K $152.4K $492.0K $18.6K
Receivables 12-point trend, +67583.2% $217.3K $113.1K $140.6K $77.1K $50.5K $21.7K $7.6K $225.9K $86.7K $2.8K $1.3K $321
Inventory 12-point trend, +260.7% $225.3K $219.8K $264.5K $263.6K $287.8K $265.4K $101.4K $43.5K $58.9K $85.2K $65.4K $62.5K
Prepaid Expense 12-point trend, +241145.00 $241.1K $180.9K $622.3K $190.2K $282.8K $157.7K $195.9K $249.5K $63.0K $11.0K $0 $0
Current Assets 12-point trend, +3292.4% $3M $1M $1M $621.1K $6M $11M $2M $731.1K $234.4K $251.4K $558.8K $81.4K
PP&E (Net) 12-point trend, +386165.00 $386.2K $466.7K $826.4K $436.7K $501.4K $132.2K $93.1K $34.4K $15.7K $15.7K $0 $0
Accum. Depreciation 8-point trend, +1179.7% $459.6K $335.7K $233.6K $153.3K $78.2K $52.3K $42.1K $35.9K · · · ·
Goodwill Flat — no change across 3 periods $6M $6M $6M · · · · · · · · ·
Intangibles 11-point trend, +4872.6% $1M $3M $4M · $132.1K $95.0K $7.2K $11.8K $16.3K $19.1K $21.0K $26.6K
Other Non-current Assets 7-point trend, +923.0% · · · · · $272.6K $159.0K $11.8K $16.3K $19.1K $21.0K $26.6K
Total Assets 12-point trend, +18613.5% $20M $46M $19M $4M $10M $11M $2M $777.3K $266.4K $286.2K $579.8K $108.1K
Accounts Payable 12-point trend, +66.1% $2M $3M $2M $1M $443.4K $328.9K $371.5K $571.8K $960.7K $974.9K $1M $1M
Short-term Debt 5-point trend, +100000.00 · · · $100.0K · $157.6K $0 $131.7K $0 · · ·
Current Liabilities 12-point trend, +131.3% $10M $18M $8M $3M $1M $2M $2M $4M $5M $5M $4M $4M
Capital Leases 8-point trend, +1171075.00 $1M $1M $3M $1M $2M $58.6K $81.5K $0 · · · ·
Deferred Tax 6-point trend, +163115.00 · $163.1K · $1.9K $1.1K $469 $433 $0 · · · ·
Total Liabilities 12-point trend, +190.9% $13M $26M $18M $5M $3M $5M $6M $4M $5M $5M $4M $4M
Long-term Debt 2-point trend, -88.0% $892.5K $7M · · · · · · · · · ·
Total Debt · · · · · · $0 · · · · ·
Common Stock 12-point trend, -98.0% $239 $37 $20 $61 $1.2K $964 $489 $15.4K $14.2K $14.1K $13.7K $12.0K
Paid-in Capital 8-point trend, +612.0% · · · · $46M $38M $20M $19M $14M $13M $12M $6M
Retained Earnings 12-point trend, -741.4% $-91M $-67M $-58M $-50M $-39M $-32M $-24M $-22M $-19M $-18M $-16M $-11M
Stockholders' Equity 12-point trend, +265.7% $7M $13M $892.8K $-977.6K $7M $6M $-4M $-3M $-5M $-5M $-4M $-4M
Liabilities + Equity 12-point trend, +18613.5% $20M $46M $19M $4M $10M $11M $2M $777.3K $266.4K $286.2K $579.8K $108.1K
Shares Outstanding 12-point trend, -99.6% 477,366 3,111 207,711 608,611 11,929,147 9,639,268 4,884,879 4,821,641 142,132,374 140,596,646 137,085,646 119,732,270
Flusso di cassa 15
Dati annuali Flusso di cassa per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
D&A 12-point trend, +6332.1% $677.4K $919.6K $200.9K $77.3K $27.8K $11.9K $10.8K $5.2K $2.8K $1.9K $5.6K $10.5K
Stock-based Comp 6-point trend, +162920.00 $162.9K · · $2M $2M $1M $69.8K $0 · · · ·
Deferred Tax Flat — no change across 3 periods · · · · · · · · · $0 $0 $0
Amort. of Intangibles 7-point trend, +12042.0% $553.4K $817.5K $120.6K $1.8K $1.8K $1.8K $4.6K · · · · ·
Other Non-cash 5-point trend, -35.9% · · $3M · · · $3M · $518.1K $2M $5M ·
Operating Cash Flow 12-point trend, -36055.3% $-7M $-3M $-5M $-7M $-6M $-5M $1M $-653.0K $-181.3K $-323.9K $-151.6K $-19.4K
CapEx 11-point trend, +43412.00 $43.4K $183.7K $444.7K $10.8K $415.7K $49.3K $64.8K $19.4K $0 $15.7K $0 ·
Investing Cash Flow 11-point trend, -2745481.00 $-3M $363.9K $-2M $-81.2K $-2M $-187.3K $-114.7K $-19.4K $0 $-15.7K $0 ·
Stock Issued 12-point trend, +61678.0% $12M $165.1K $6M $289.8K $4M $11M $0 $47.0K $54.6K $0 $645.0K $20.0K
Net Stock Activity 5-point trend, +784.0% · · $6M · · · $0 · $54.6K $0 $645.0K ·
Financing Cash Flow 12-point trend, +55382.1% $11M $3M $7M $1M $4M $14M $-229.5K $858.9K $54.6K $0 $625.0K $20.0K
Net Change in Cash 11-point trend, +223012.9% $1M $509.0K $142.3K $-6M $-4M $9M · $186.5K $-126.6K $-339.6K $473.4K $599
Taxes Paid 3-point trend, -24.7% · · · $800 $3.3K $1.1K · · · · · ·
Free Cash Flow 4-point trend, -1431.1% · · $-5M · · · $1M · $-181.3K $-339.6K · ·
Levered FCF 4-point trend, -1634.1% · · $-6M · · · $926.6K · $-202.1K $-353.4K · ·
Redditività 8
Dati annuali Redditività per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Gross Margin 4-point trend, +172.9% · · · · · · 90.6% · 81.6% 70.3% 33.2% ·
Operating Margin 5-point trend, +95.6% · · -224.0% · · · -120.8% · -227.0% -4146.1% -5090.9% ·
Net Margin 5-point trend, +99.4% · · -266.0% · · · -146.4% · -248.9% -4173.3% -42426.6% ·
Pretax Margin 5-point trend, +99.4% · · -265.1% · · · -146.4% · -248.9% -4173.3% -42426.6% ·
EBITDA Margin 5-point trend, +95.7% · · -217.4% · · · -120.1% · -226.0% -4142.4% -5042.7% ·
ROA 4-point trend, +86.8% · · · · · · -168.5% · -254.1% -490.6% -1273.3% ·
ROE 4-point trend, -54.0% · · · · · · 58.0% · 14.6% 50.7% 126.2% ·
ROIC 4-point trend, +204.0% · · · · · · 48.2% · 12.8% 45.7% 15.8% ·
Liquidità e Solvibilità 4
Dati annuali Liquidità e Solvibilità per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Current Ratio 4-point trend, +698.3% · · · · · · 1.0 · 0.0 0.1 0.1 ·
Quick Ratio 4-point trend, +629.4% · · · · · · 0.8 · 0.0 0.0 0.1 ·
Debt / Equity · · · · · · 0.0 · · · · ·
Interest Coverage 5-point trend, +60.7% · · -7.3 · · · -4.7 · -30.7 -152.5 -18.6 ·
Efficienza 3
Dati annuali Efficienza per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Asset Turnover 4-point trend, +3735.7% · · · · · · 1.2 · 1.0 0.1 0.0 ·
Inventory Turnover 3-point trend, +862.0% · · · · · · 1.9 · 0.7 0.2 · ·
Receivables Turnover 4-point trend, +46.0% · · · · · · 12.7 · 6.3 24.6 8.7 ·
Per Azione 5
Dati annuali Per Azione per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Book Value / Share 4-point trend, +13.1% · · · · · · $-0.02 · $-0.04 $-0.03 $-0.03 ·
Revenue / Share 5-point trend, +1928800.0% · · $1.93 · · · $0.01 · $0.00 $0.00 $0.00 ·
Cash Flow / Share 5-point trend, -252941.7% · · $-3.04 · · · $0.01 · $-0.00 $-0.00 $-0.00 ·
Cash / Share 4-point trend, +119.4% · · · · · · $0.01 · $0.00 $0.00 $0.00 ·
EPS (TTM) 11-point trend, -536500.0% $-214.64 $-30.19 $-67.37 $-17.97 $-0.63 $-1.52 $-0.45 $-0.02 $0.00 $-0.02 $-0.04 ·
Tassi di Crescita 3
Dati annuali Tassi di Crescita per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -98.4% 4.7% 116.3% 267.4% -80.2% 301.1% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +139.8% 102.6% 16.2% 42.8% · · · · · · · · ·
Revenue CAGR 5Y 45.8% · · · · · · · · · · ·
Valutazione (TTM) 5
Dati annuali Valutazione (TTM) per IVF
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue TTM 11-point trend, +58427.2% $7M $7M $3M $822.2K $4M $1M $1M $494.4K $282.1K $50.9K $11.7K ·
Net Income TTM 11-point trend, -370.3% $-23M $-9M $-8M $-11M $-7M $-8M $-2M $-3M $-702.2K $-2M $-5M ·
P/E 6-point trend, +100.0% -0.0 -1.0 -0.7 -17.0 -3805.7 -1425.8 · · · · · ·
P / Tangible Book 4-point trend, -99.5% 17.9 3.0 · · 3984.3 3698.6 · · · · · ·
Earnings Yield 6-point trend, -40720828.6% -28504.6% -103.5% -138.6% -5.9% -0.03% -0.07% · · · · · ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312024-03-312023-12-312023-09-30
Ricavi $7M$7M$3M
Margine Operativo % -224.0%
Utile netto $-23M$-9M$-8M
EPS Diluito $-214.64$-3782.65$-67.37
Flusso di cassa
2025-12-312024-12-312024-03-312023-12-312023-09-30
Flusso di cassa libero $-5M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 2 filer · $1 totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
0 (-1 vs trimestre precedente) 1 (-8 vs trimestre precedente) 0 (0 vs trimestre precedente) 0 (0 vs trimestre precedente) -13

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
Westfuller Advisors, LLC $1 1 100,00% Azioni
HUNTINGTON NATIONAL BANK $0 1 0,00% Azioni

Insider aziendali 10 insider · 3 dirigenti · 9 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Steve Shum Chief Executive Officer 31 Dicembre 2020 A 1.000.000 0 0 $0
Michael Jos. Campbell Chief Operating Officer 31 Dicembre 2020 A 1.607.800 0 0 $0
Kevin Doody Medical Director 31 Dicembre 2020 A 169.821 0 0 $0
Jeffrey Segal Direttore 31 Dicembre 2020 A 9.975 0 0 $0
Barbara Ryan Direttore 31 Dicembre 2020 A 12.465 0 0 $0
Matthew K Szot Direttore 31 Dicembre 2020 A 14.451 0 0 $0
Trent D Davis Direttore 31 Dicembre 2020 A 13.573 0 0 $0
Kathleen T Karloff Direttore 05 Febbraio 2020 A 13.200.183 0 0 $0
Robert Joseph Bowdring Jr Direttore 29 Ottobre 2019 J 11.715.942 0 0 $0
Claude Ranoux 11 Dicembre 2017 S 26.233.122 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 2 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
SS. OR ×3 depositi 08 Agosto 2017 Deposito iniziale SEC
Persona segnalante non divulgata 19 Giugno 2017 Deposito iniziale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.